A 52-year-old man from rural Maharashtra presents with a 6-month history of progressive weakness, polyuria, and polydipsia. On examination, blood pressure is 168/104 mmHg. Laboratory investigations reveal: serum sodium 148 mEq/L, serum potassium 2.8 mEq/L, serum bicarbonate 32 mEq/L, and plasma renin activity is suppressed (0.3 ng/mL/hr; normal 0.5–1.5). Plasma aldosterone is markedly elevated at 28 ng/dL (normal <15). Abdominal CT shows a 2 cm left adrenal nodule. Which mechanism best explains the suppressed renin activity in this patient?

Explanation

## Clinical Context This patient presents with **primary aldosteronism** (Conn syndrome) due to an adrenal adenoma. The hallmark is autonomous aldosterone secretion independent of the renin-angiotensin system. ## Mechanism of Suppressed Renin **Key Point:** In primary aldosteronism, suppressed plasma renin activity (PRA) is a cardinal finding that distinguishes it from secondary hyperaldosteronism. The elevated aldosterone causes: 1. **Sodium retention** in the collecting duct → increased intravascular volume 2. **Hypervolemia** → increased renal perfusion pressure 3. **Reduced sodium delivery** to the macula densa (via increased proximal tubular reabsorption) 4. **Decreased juxtaglomerular cell stimulation** → suppressed renin secretion This is a **negative feedback loop** operating at the level of the juxtaglomerular apparatus, not direct inhibition by Ang II. ## Why This Differs from Secondary Hyperaldosteronism | Feature | Primary Aldosteronism | Secondary Hyperaldosteronism | |---------|----------------------|------------------------------| | **PRA** | Suppressed (<1 ng/mL/hr) | Elevated (>2 ng/mL/hr) | | **Aldosterone** | Elevated | Elevated | | **Aldo/PRA ratio** | >20–30 | <10 | | **Volume status** | Expanded (despite HTN) | Contracted (cirrhosis, heart failure) | | **Mechanism** | Autonomous adrenal production | Appropriate RAAS activation | **Clinical Pearl:** The suppressed PRA with elevated aldosterone is the diagnostic hallmark of primary aldosteronism and reflects **volume-mediated suppression of renin release**, not Ang II-mediated inhibition. **High-Yield:** In this patient's labs: - Hypokalemia (K 2.8) → from aldosterone-induced urinary potassium wasting - Metabolic alkalosis (HCO~3~ 32) → from hypokalemia-induced H^+^ retention and ammonia reabsorption - Hypertension + hypokalemia + suppressed PRA = **diagnostic triad of primary aldosteronism**